ClinicalTrials.gg
Enrolling by invitationNCT07256574Updated Dec 26, 2025

Sun-Kissed Serenity: Morning Rays for a Brighter Mind

An interventional study of Morning sunlight in Mental Status Change, sponsored by Efforia, Inc. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Efforia, Inc · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Sun-Kissed Serenity: Morning Rays for a Brighter Mind is a 30-day dawn rendezvous with nature. Participants are asked to stand outside for 15 minutes each morning, track progress with surveys, and support mental health with natural light.

Read the detailed description

This remotely administered decentralized trial is designed to meticulously evaluate the impact of daily morning sunlight exposure on mental well-being over a span of 30 days. In an era where society is increasingly fraught with overstimulation and stress, this study seeks to explore a simple, natural intervention that has been both scientifically and anecdotally linked to improved mental health outcomes. Leveraging the NIH Toolbox® Positive Affect Survey and the Personal Feelings Survey, this online study aims to quantify the effects of a 15-minute morning sunlight exposure routine on participants' mood, stress levels, and overall sense of well-being.

The objective behind this innovative approach is to empower individuals to discover the potential mental health benefits of integrating a brief period of sunlight exposure into their daily morning routine. By participating in this trial, individuals are not only taking an active step towards potentially enhancing their own mental wellness but are also contributing valuable data to a broader scientific endeavor aimed at validating a cost-free, accessible method for supporting mental health.

This study will utilize a variety of validated tools to rigorously assess changes in participants' emotional states and personal well-being throughout the trial period. This includes tracking shifts in positive affect, stress levels, and overall mood, to determine whether this straightforward daily practice can yield significant improvements in mental health metrics.

The significance of this study lies in its potential to offer a low-cost, universally accessible intervention for enhancing mental wellness without the need for pharmaceuticals, subscriptions, or the risk of adverse side effects. Despite variables such as weather conditions or individual daily routines, the prospect of establishing a free, evidence-based practice for reducing stress and elevating mood holds considerable promise. Through this remotely conducted trial, the investigators aim to gather conclusive evidence on the efficacy of morning sunlight exposure as a tool for mental health support, thereby contributing to the development of simple, natural strategies for managing stress and improving emotional well-being in today's fast-paced world.

02

Conditions studied

  • Mental Status Change
03

In context

Lead sponsor

Efforia, Inc is the lead sponsor of 25 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Single arm where participants act as their own control

    Single arm where participants act as their own control

    Behavioral: Morning sunlight

Interventions

  • BehavioralMorning sunlight

    Participants are asked to get 15 minutes of morning sunlight every day for 30 days.

06

What researchers measure

Primary outcomes

  1. NIH Toolbox® Item Bank v3.0 - Positive Affect Survey (Ages 18+) Score

    This survey assesses your level of positive affect in the past 7 days. Please respond to each question or statement by selecting one option that best describes your feelings or experiences.

    Time frame: Change from baseline (Day 1-3) in positive affect scores at 4 weeks after the start of the intervention (Day 28-32)

  2. Personal Feelings Survey

    This survey aims to understand your personal feelings, particularly about being alone or feeling isolated. You are asked to indicate how often you feel a certain way.

    Time frame: Change from baseline (Day 1-3) in feelings of isolation scores at 4 weeks after the start of the intervention (Day 28-32)

07

Study locations

1 site
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2025 (actual). Primary completion is estimated for Sep 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2025
First posted
Dec 1, 2025
StartActual
Sep 11, 2025
Primary completionEst.
Sep 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Dec 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07256574
Lead sponsor
Efforia, Inc
Responsible party
Sponsor
First posted
Dec 1, 2025
Start date
Sep 11, 2025
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Dec 26, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion